Systematic literature review on Calcium Pyrophosphate Deposition (CPPD) nomenclature: condition elements and clinical states— A Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus project
Authors' conclusion
Those results demonstrate the heterogeneity of labels used to describe CPPD condition concepts, with wide variation in condition labels in the medical literature.
Study context
- Population
- Medical literature on CPPD, 2000–2022articles included of 2375 identified
- Participants
- 886 participants
- Outcome
- Frequency of labels used for CPPD concepts (pathogenic conditions and crystals, imaging condition elements, asymptomatic and symptomatic condition states)
Methodological detailsG-CAN consensus project, PubMed, Cochrane and Embase, 2000–2022, English language, human studies, eight independent reviewers, a priori list of concepts
- G-CAN consensus project
- PubMed, Cochrane and Embase, 2000–2022
- English language, human studies
- Eight independent reviewers, a priori list of concepts
Recommendations
As reported in the abstract
Most common labels for the pathogenic condition
'pseudogout'
365 of 783
46.6%
'chondrocalcinosis'
207 of 783
26.4%
'calcium pyrophosphate deposition disease'
181 of 783
23.1%
Most common abbreviation 'CPPD', with different meanings
312 of 390
80.0%
Further findings
Article types among included articles
- Case reports
- 394 (44.5%)
- Scoping reviews
- 169 (19.0%)
Original publication
Systematic literature review on Calcium Pyrophosphate Deposition (CPPD) nomenclature: condition elements and clinical states— A Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus project. RMD Open. Published 30 January 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →